- Home
- CRNX vs PIPR Comparison
CRNX vs PIPR Comparison
Compare CRNX & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- PIPR
- Stock Information
- Founded
- CRNX 2008
- PIPR 1895
- Country
- CRNX United States
- PIPR United States
- Employees
- CRNX N/A
- PIPR N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- PIPR Investment Bankers/Brokers/Service
- Sector
- CRNX Health Care
- PIPR Finance
- Exchange
- CRNX Nasdaq
- PIPR Nasdaq
- Market Cap
- CRNX 5.3B
- PIPR 4.6B
- IPO Year
- CRNX 2018
- PIPR N/A
- Fundamental
- Price
- CRNX $54.72
- PIPR $336.53
- Analyst Decision
- CRNX Strong Buy
- PIPR Buy
- Analyst Count
- CRNX 10
- PIPR 3
- Target Price
- CRNX $73.70
- PIPR $193.00
- AVG Volume (30 Days)
- CRNX 655.3K
- PIPR 126.4K
- Earning Date
- CRNX 11-12-2024
- PIPR 10-25-2024
- Dividend Yield
- CRNX N/A
- PIPR 0.77%
- EPS Growth
- CRNX N/A
- PIPR 122.99
- EPS
- CRNX N/A
- PIPR 9.33
- Revenue
- CRNX $1,038,999.00
- PIPR $1,513,658,000.00
- Revenue This Year
- CRNX N/A
- PIPR $13.28
- Revenue Next Year
- CRNX $494.25
- PIPR $16.11
- P/E Ratio
- CRNX N/A
- PIPR $36.02
- Revenue Growth
- CRNX N/A
- PIPR 19.45
- 52 Week Low
- CRNX $28.50
- PIPR $151.03
- 52 Week High
- CRNX $62.53
- PIPR $347.15
- Technical
- Relative Strength Index (RSI)
- CRNX 41.37
- PIPR 66.54
- Support Level
- CRNX $58.21
- PIPR $278.14
- Resistance Level
- CRNX $62.53
- PIPR $344.64
- Average True Range (ATR)
- CRNX 2.48
- PIPR 9.38
- MACD
- CRNX -0.33
- PIPR 3.04
- Stochastic Oscillator
- CRNX 4.87
- PIPR 84.61
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About PIPR Piper Sandler Companies
Piper Sandler Cos is an investment banking company. Investment banking services include financial advisory services, management of and participation in underwriting, and public finance activities. It generates maximum revenue from Advisory services followed by Equity financing. The company focuses on the following sectors: healthcare; energy; consumer; diversified industrials and services; business services; technology; financial services; agriculture, clean technologies, and renewables, focusing on middle-market clients.